Drugs for Inhibited Female Orgasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 26)
| # |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
| 1 |
|
Dopamine |
Approved |
Phase 2, Phase 3 |
|
51-61-6, 62-31-7 |
681
|
|
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
|
Hydroxytyramin
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
| 2 |
|
Bupropion |
Approved |
Phase 2, Phase 3 |
|
34841-39-9, 34911-55-2 |
444
|
|
Synonyms:
( -)-2-(tert-Butylamino)-3'-chloropropiophenone
( -)-2-(tert-Butylamino)-3'-chlorpropiophenon
(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
.alpha.-(tert-Butylamino)-m-chloropropiophenone
1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
2-(Tert-Butylamino)-3'-chloropropiophenone
34841-36-6 (hydrochloride)
34841-39-9
34911-55-2
AB00053756
AC-197
AC1L198Y
alpha-(tert-butylamino)-m-chloropropiophenone
Amfebutamon
Amfebutamona
Amfebutamona [INN-Spanish]
Amfebutamone
AMFEBUTAMONE HCl
amfebutamonum
Amfebutamonum
Amfebutamonum [INN-Latin]
BPBio1_000042
BRD-A05186015-003-05-7
BRN 2101062
BSPBio_000038
BSPBio_002247
bupropion
Bupropion (INN)
Bupropion (Old RN)
Bupropion (USAN)
Bupropion [INN:BAN]
Bupropion Hcl
Bupropion hydrochloride
Bupropion hydrochloride, (+-)-isomer
Bupropion hydrocloride
Bupropion SR
Bupropion, (+-)-isomer
C06860
CHEBI:3219
CHEMBL894
CID444
CPD000472526
D07591
DB01156
DivK1c_007050
Elont
|
Esteve brand OF bupropion hydrochloride
glaxo Wellcome brand 1 OF bupropion hydrochloride
glaxo Wellcome brand 2 OF bupropion hydrochloride
glaxo Wellcome brand 3 OF bupropion hydrochloride
GlaxoSmithKline brand 1 OF bupropion hydrochloride
GlaxoSmithKline brand 2 OF bupropion hydrochloride
HMS2051G10
HMS2089G14
Jsp006301
KBio1_001994
KBio2_002143
KBio2_004711
KBio2_007279
KBio3_001467
KBioGR_001168
KBioSS_002143
L000725
Lopac0_000166
LS-122817
MLS001424015
MolPort-003-845-432
NCGC00015122-06
NCGC00089751-02
NCI60_002714
NSC315851
Prestwick0_000249
Prestwick1_000249
Prestwick2_000249
Prestwick3_000249
Quomen
SAM001246699
SMR000472526
SPBio_001817
SPBio_002257
SpecPlus_000954
Spectrum_001663
Spectrum2_001659
Spectrum3_000644
Spectrum4_000614
Spectrum5_001406
TL8002604
UNII-01ZG3TPX31
Wellbatrin
Wellbutrin
Wellbutrin SR
Wellbutrin XL
Zyban
Zyban (anti-smoking)
Zyntabac
|
|
| 3 |
|
Psychotropic Drugs |
|
Phase 2, Phase 3 |
|
|
|
| 4 |
|
Antidepressive Agents |
|
Phase 2, Phase 3 |
|
|
|
| 5 |
|
Antidepressive Agents, Second-Generation |
|
Phase 2, Phase 3 |
|
|
|
| 6 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
| 7 |
|
Dopamine Uptake Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
| 8 |
|
Neurotransmitter Uptake Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
| 9 |
|
Neurotransmitter Agents |
|
Phase 2, Phase 3 |
|
|
|
| 10 |
|
Dopamine Agents |
|
Phase 2, Phase 3 |
|
|
|
| 11 |
|
Cytochrome P-450 CYP2D6 Inhibitors |
|
Phase 2, Phase 3 |
|
|
|
| 12 |
|
Testosterone enanthate |
Approved |
Phase 2 |
|
315-37-7 |
9416
|
|
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
17beta-Hydroxyandrost-4-en-3-one heptanoate
17beta-Hydroxyandrost-4-en-3-one heptanoic acid
17b-Hydroxyandrost-4-en-3-one heptanoate
17b-Hydroxyandrost-4-en-3-one heptanoic acid
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17β-hydroxyandrost-4-en-3-one heptanoate
17β-hydroxyandrost-4-en-3-one heptanoic acid
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn l.a.
Andropository
Androtardyl
Atlatest
BTG Brand OF testosterone enanthate
DEA no. 4000
Delatest
Delatestryl
DePatestrye
depo-testro Med
Ditate
Durathate
eifelfango Brand OF testosterone enanthate
Everone
Exten test
Jenapharm brand OF testosterone enanthate
Malogen l.a.
Malogen l.a.200
Orquisteron-e
Pasadena brand OF testosterone enanthate
|
Primoteston depot
Primotestone
reposo TMD
Roberts brand OF testosterone enanthate
Rotexmedica brand OF testosterone enanthate
Rugby brand OF testosterone enanthate
Schering brand OF testosterone enanthate
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosteron depot-rotexmedica
Testosteron-depot eifelfango
Testosteron-depot jenapharm
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone 17-enanthate
Testosterone 17-enanthic acid
Testosterone enantate
Testosterone enanthic acid
Testosterone heptanoate
Testosterone heptanoic acid
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
Testrin p.a.
Theramed brand OF testosterone enanthate
Theramex
|
|
| 13 |
|
Testosterone |
Approved, Investigational |
Phase 2 |
|
58-22-0 |
6013
|
|
Synonyms:
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
17 alpha Testosterone
17?-Hydroxy-4-androsten-3-one
17a-cis-Testosterone
17-alpha-Testosterone
17beta-Hydroxy-3-oxo-4-androstene
17beta-hydroxy-4-androsten-3-one
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17-beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17b-hydroxy-4-androsten-3-one
17-Epitestosterone
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-(17-beta)-androst-4-en-3-one
46923_FLUKA
46923_RIEDEL
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
Androderm
Androderm (TN)
Androgel
AndroGel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17beta-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
beta testosterone
Beta Testosterone
BIDD:ER0555
BIM-0061761.0001
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
cis-Testosterone
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
DB00624
Dea No. 4000
Delatest
Delatestryl
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
Depotest
Depo-Testosterone
Depo-Testosterone Cypionate
EINECS 200-370-5
Epi-testosterone
Everone 200
Geno-cristaux gremy
Geno-Cristaux Gremy
Halotensin
HMS2052N11
Homosteron
Homosterone
HSDB 3398
Intrinsa
Isotestosterone
Libigel
LibiGel
LMST02020002
LS-148813
Malerone
|
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, aquaspension injection
Malogen, Aquaspension Injection
Mertestate
Metandren
Methyltestosterone
MLS000563091
MLS001032098
MLS001306401
MLS002174283
MolPort-002-506-901
NCGC00091018-01
Neo-Hombreol F
Neotestis
Neo-testis
Neo-Testis
NSC 9700
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine androgenique
Percutacrine Androgenique
Primotest
Primoteston
Relibra
S00309
S2033_Selleck
SAM001246921
Scheinpharm Testone-Cyp
SMR000058344
SMR001261453
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
T-Cypionate
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
testosterone
Testosterone
Testostérone
Testosterone (JAN/USP)
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone Cypionate
Testosterone Enanthate
Testosterone hydrate
Testosterone Hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testoviron
Testoviron Schering
Testoviron T
Testred
Testred Cypionate 200
Testrin-P.A
Testro Aq
Testro AQ
Testrone
Testryl
trans-Testosterone
Trans-Testosterone
UNII-3XMK78S47O
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
|
|
| 14 |
|
Testosterone undecanoate |
Approved, Investigational |
Phase 2 |
|
5949-44-0 |
|
|
Synonyms:
|
| 15 |
|
Methyltestosterone |
Approved |
Phase 2 |
|
58-18-4 |
6010
|
|
Synonyms:
17 alpha Methyltestosterone
17 beta Hydroxy 17 methyl 4 androsten 3 one
17 beta Methyltestosterone
17 beta-Hydroxy-17-methyl-4-androsten-3-one
17 beta-Methyltestosterone
17 Epimethyltestosterone
17(a)-Methyl-delta(4)-androsten-17(b)-ol-3-one
17(a)-Methyl-δ(4)-androsten-17(b)-ol-3-one
17(alpha)-Methyl-Delta(4)-androsten-17(beta)-ol-3-one
17(α)-methyl-δ(4)-androsten-17(β)-ol-3-one
17alpha Methyl testosterone
17alpha Methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-Delta(4)-androsten-17beta-ol-3-one
17alpha-Methyl-delta-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-Methyl-testosterone
17-alpha-Methyltestosterone
17a-Methyl-3-oxo-4-androsten-17b-ol
17a-Methyl-delta(4)-androsten-17b-ol-3-one
17a-Methyltestosterone
17a-Methyl-δ(4)-androsten-17b-ol-3-one
17beta Hydroxy 17 methyl 4 androsten 3 one
17beta Methyltestosterone
17beta-Hydroxy-17-methyl-4-androsten-3-one
17beta-Hydroxy-17-methylandrost-4-en-3-one
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17beta-Methyltestosterone
17b-Hydroxy-17-methylandrost-4-en-3-one
17-b-Hydroxy-17-methylandrost-4-en-3-one
17-Epimethyltestosterone
17-methyltestosterone
17-Methyltestosterone
|
17α-methyl-3-oxo-4-androsten-17β-ol
17α-methyltestosterone
17α-methyl-δ(4)-androsten-17β-ol-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17β-hydroxy-17-methylandrost-4-en-3-one
17-β-hydroxy-17-methylandrost-4-en-3-one
4-Androstene-17alpha-methyl-17beta-ol-3-one
4-Androstene-17a-methyl-17b-ol-3-one
4-Androstene-17α-methyl-17β-ol-3-one
Android
Android 10
Android 25
Android 5
Android-10
Android-25
Android-5
Global pharmaceutical brand OF methyltestosterone
ICN brand 1 OF methyltestosterone
ICN brand 2 OF methyltestosterone
Mesteron
Mesterone
Metandren
Methitest
Methyltestosteronum
Metiltestosterona
NSC-9701
Oreton
Schering brand OF methyltestosterone
Star brand OF methyltestosterone
Testoviron
Testred
Virilon
|
|
| 16 |
|
Paroxetine |
Approved, Investigational |
Phase 2 |
|
61869-08-7 |
43815
|
|
Synonyms:
(−)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(P-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine
(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine
(-)-Paroxetine
(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine
(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine
(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine
(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine
[3H]Paroxetine
110429-35-1
3-(Benzo[1,3]Dioxol-5-Yl-Oxymethyl)-4-(4-Fluoro-Phenyl)-Piperidine Hydrochloride
61869-08-7
63952-24-9
64006-44-6 (maleate)
78246-49-8 (hydrochloride)
AB00514724
AC1L2AKL
AC1Q1H18
AC1Q4LV6
Acetate, paroxetine
Anhydrous, paroxetine hydrochloride
Aropax
BIDD:GT0673
BPBio1_000949
BRD-K37991163-003-02-7
BRL 29060
BRL-29060
BSPBio_000861
C07415
C19H20FNO3
Casbol
CHEBI:7936
CHEMBL490
CID43815
D02362
DB00715
DivK1c_006884
FG 7051
FG-7051
Frosinor
FT-0085087
Hemihydrate paroxetine hydrochloride
Hemihydrate, paroxetine hydrochloride
HMS2090H05
Hydrochloride anhydrous, paroxetine
Hydrochloride hemihydrate, paroxetine
Hydrochloride, hemihydrate paroxetine
|
Hydrochloride, paroxetine
I14-7752
KBio1_001828
KBio2_002232
KBio2_004800
KBio2_007368
KBioSS_002232
LS-114249
Maleate, paroxetine
MolPort-003-849-791
Motivan
NCGC00025355-02
NCGC00025355-03
NCGC00025355-04
NCGC00025355-05
NCGC00025355-06
NCGC00025355-07
NCGC00025355-08
NNC-20-7051
Paroxetina
Paroxetina [INN-Spanish]
paroxetine
Paroxetine (TN)
Paroxetine (USP/INN)
Paroxetine [USAN:INN:BAN]
Paroxetine acetate
Paroxetine Hcl
Paroxetine hydrochloride
Paroxetine hydrochloride anhydrous
Paroxetine hydrochloride hemihydrate
Paroxetine hydrochloride, hemihydrate
Paroxetine maleate
Paroxetine, cis-(-)-isomer
Paroxetine, cis-(+)-isomer
Paroxetine, trans-(+)-isomer
Paroxetinum
Paroxetinum [INN-Latin]
Paxetil
Paxil
Paxil CR
PaxPar
Pexeva
Prestwick3_000851
Seroxat
Seroxat CR
SpecPlus_000788
Spectrum_001752
Spectrum5_001665
TL8003967
UNII-41VRH5220H
|
|
| 17 |
|
Sertraline |
Approved |
Phase 2 |
|
79617-96-2 |
68617
|
|
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-sertraline
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-Dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Altruline
apo Sertraline
apo-Sertraline
Apo-Sertraline
Apotex brand OF sertraline hydrochloride
Aremis
Besitran
BIDD:GT0768
BIDD:PXR0193
Boehringer ingelheim brand OF sertraline hydrochloride
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
cis-(+)-sertraline
cis-(+)-Sertraline
Cp 51974
CP 51974
D02360
DB01104
DB08567
Esteve brand OF sertraline hydrochloride
FT-0081122
Gen sertraline
Genpharm brand OF sertraline hydrochloride
Gen-sertraline
Gladem
HSDB 7037
Hydrochloride, sertraline
|
KBio3_001918
KBioGR_001724
Lacer brand OF sertraline hydrochloride
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
novo Sertraline
Novopharm brand OF sertraline hydrochloride
novo-Sertraline
Parke davis brand OF sertraline hydrochloride
Pfizer brand OF sertraline hydrochloride
Prestwick3_001014
ratio Sertraline
Ratiopharm brand OF sertraline hydrochloride
ratio-Sertraline
Rhoxal sertraline
Rhoxalpharma brand OF sertraline hydrochloride
Rhoxal-sertraline
Roerig brand OF sertraline hydrochloride
Sealdin
Sertralina
Sertralina [Spanish]
sertraline
Sertraline
Sertraline (INN)
sertraline (Zoloft)
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertraline Hydrochloride
Sertraline hydrochloride (1S-cis)-isomer
Sertralinum
Sertralinum [Latin]
SMR000596516
SPBio_000385
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
SRE
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
|
|
| 18 |
|
Fluoxetine |
Approved, Vet_approved |
Phase 2 |
|
54910-89-3 |
3386
|
|
Synonyms:
(+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine
(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine
(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
(+/-)-Fluoxetine
(+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine
(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine
(+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine]
(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine
3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
52341-67-0
54910-89-3
57226-07-0
59333-67-4 (hydrochloride)
AB00053774
AC-14564
AC1L1FTH
Adofen
AKOS003663021
Animex-On
Bio-0787
Biomol-NT_000152
BPBio1_000354
BPBio1_000509
BRD-A31159102-001-01-9
BRD-A31159102-003-05-6
BSPBio_000461
BSPBio_003375
C17H18F3NO
CHEBI:5118
CHEMBL41
CID3386
D00326
DB00472
Deprex
DivK1c_006819
dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine
Eufor
Floxetine
Fluctin
Fluoxeren
Fluoxetin
Fluoxetina
Fluoxetina [INN-Spanish]
Fluoxetina [Spanish]
fluoxetine
Fluoxétine
fluoxetine (Prozac)
Fluoxetine (TN)
Fluoxetine (USAN/INN)
Fluoxetine [USAN:INN:BAN]
Fluoxetine Hcl
|
Fluoxetine hydrochloride
Fluoxetine Hydrochloride
Fluoxetinum
Fluoxetinum [INN-Latin]
Fluval
Fontex
Foxetin
HMS2090H14
KBio1_001763
KBio2_002159
KBio2_004727
KBio2_007295
KBio3_002595
KBioGR_001166
KBioSS_002159
L000931
Lilly-110140
Lopac0_000558
LS-31040
Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine
Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine
MolPort-001-683-482
NCGC00015428-10
NCGC00024879-03
NCGC00024879-04
nchembio.534-comp2
N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine
N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine
N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine
NSC283480
Portal
Prestwick0_000511
Prestwick1_000511
Prestwick2_000511
Prestwick3_000511
Prozac
Prozac Weekly
Pulvules
Reconcile
Reneuron
Sarafem
SPBio_001815
SPBio_002382
SpecPlus_000723
Spectrum_001679
Spectrum2_001658
Spectrum3_001648
Spectrum4_000613
Spectrum5_001518
STK734483
Symbyax
TL8003595
UNII-01K63SUP8D
|
|
| 19 |
|
Antineoplastic Agents, Hormonal |
|
Phase 2 |
|
|
|
| 20 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 2 |
|
|
|
| 21 |
|
Androgens |
|
Phase 2 |
|
|
|
| 22 |
|
Hormone Antagonists |
|
Phase 2 |
|
|
|
| 23 |
|
Testosterone 17 beta-cypionate |
|
Phase 2 |
|
|
|
| 24 |
|
Hormones |
|
Phase 2 |
|
|
|
| 25 |
|
Anabolic Agents |
|
Phase 2 |
|
|
|
| 26 |
|
Ginkgo |
|
Phase 2 |
|
|
|
Interventional clinical trials:
| # |
Name |
Status |
NCT ID |
Phase |
Drugs |
| 1 |
Female Orgasmic Disorder (FOD) and Wellbutrin XL |
Completed |
NCT00248209
|
Phase 2, Phase 3 |
Wellbutrin XL |
| 2 |
Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder |
Completed |
NCT01607658
|
Phase 2 |
Placebo;Low dose TBS-2;Medium dose TBS-2;High dose TBS-2 |
| 3 |
Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction |
Completed |
NCT00034021
|
Phase 2 |
Ginkgo Biloba |
| 4 |
Platelet Rich Plasma (PRP) Peri-urethral and Clitoral Injections for the Treatment of Female Orgasmic Disorder |
Recruiting |
NCT03189238
|
Phase 2 |
|
| 5 |
Effects of Early Abuse on Adult Intimate Relationships |
Completed |
NCT01803802
|
Not Applicable |
|
|
